PROGRAMMA PRELIMINARE
SESSION 1: PROJECT MANAGEMENT
09.00-09.20 Overview Spoke 1: Cronoprogramma e milestones. L.Gizzi (CNR-INO)
09.20-09.40 Project management. D. Fornaciari (CNR-INO)
09.40-10.00 SPOKE 5 - Update. E.Bianchini (CNR-IFC)
10.15-10.45 Caffè (Aula 29)
SESSION 2: SPOKE 1: PROGRESS OF SUBPROJECTS
11.00-11.20 Sub-project(1.2)- Multi-scale modeling of high dose-rate irradiation: updates. V.Tozzini (CNR-NANO)
11.20-11.40 Sub-project(1.2)- Requirements and specifications to configure an XNAT-based platform for data collection and processing within THE project. C.Scapicchio (INFN)
11.40-12.00 Sub-project(1.1)- Toward a laser-driven VHEE radiotherapy: Monte Carlo simulations of transport and focalization. C.Panaino (CNR-INO)
12.00-12.20 Sub-project(1.1) - Dosimetry with plastic scintilaltor in electron FLASH radiotherapy. E.Ravera (UNIPI)
12.20-12.40 Sub-project(1.6)- Updates on optical imaging for Cerenkov dosimetry. E.Ciarrocchi (UNIPI-INFN)
12.40-13.00 Sub-project(1.3, 1.4, 1.5)
- Flash vs Conventional radiotherapy: melanoma cells and primary adipocytes response. A. USAI (UNIPI)
- Flash radiotherapy: a new approach for ocular melanoma. B. Di Marco
- The role of super-resolution microscopy in understanding the effects induced in vitro by different radiotherapy regimes. B. Noferi, V. Parenti
13.15-14.30 Pranzo (Buffet, Aula 29)
14.40-15.40 Sub-project(1.3, 1.4, 1.5)
- Effects of conventional and flash radiotherapy on glioblastoma and melanoma cells. B. D'Orsi (CNR-IN)
- Visual system function as a read out of in-vivo radiotherapy. G. Sansevero
- Evaluating the effects of irradiation of murine corneal collagen structures using two photon imaging. V. Pillai Rajan
- A time line for animal studies: radiotherapy on naive and melanoma mouse models. G. Scabia
- Anatomic and tissue characterization of melanoma model using high field MRI. C. Fabbri, A .Flori
- Creation of devices for optimizing in vitro experiments, beam modification and quantification of dose distribution D. Del Sarto
15.40-16.00 Sub-project(1.8)- Radiofarmaci per uso clinico: dalla produzione al trasferimento tecnologico. M.Poli (CNR-IFC), D.Volterrani (UNIPI)
16.00-16.30 Caffè (Aula 29)
16.40-17.00 Sub-project(1.7)- Ongoing activities as part of WP 1.7. L.Menichetti (CNR-IFC)
17.00-17.20 Sub-project(1.7)- Studi di imaging PET con radiotraccianti selettivi per la proteina FAP e le integrine per la valutazione del rimodellamento del microambiente tumorale in seguito a radioterapia ad altissime dosi. C.Fabbri (SSSUP; CNR-IFC)
17.20-17.40 Sub-project(1.7)- Design, optimization and synthesis of dual inhibitors against tumor-associated human Carbonic Anhydrases and Fibroblast Activation Protein (FAP-α) through the use of radiolabeling chelators. F.Carta (NEUROFARBA)
17.40 - Summary
